Submit Deal

SPLICEBIO

Summary

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 100 M

Avg. Deal Size£ 100 M

Market Context

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy